ARISGLOBAL RELOCATES TO BETTER SERVE CUSTOMERS WITH ITS TOTAL LIFE CYCLE SOLUTION

Feb 29, 2016

To further support its customers as they adopt and leverage its software solutions from the conception to commercialization of their products, ArisGlobal announces that it has relocated its offices to three key cities across the U.S.

After over 20 years in Stamford, CT corporate headquarters are now relocated to Florida. Its Global Commercial Operations (GCO) have been moved to Princeton, N.J., whilst its Global Field (GF) and Client Services (CS) will now be based in Chicago, IL. With a heavy concentration of customers in these areas, ArisGlobal will now be able to further improve its services to its core North American client base.

“We believe this move makes sense for our customers,” says Sonia Veluchamy, Managing Director. “The life sciences industry is ever evolving, and our new locations will help us be exactly where our customers need us, helping them to capitalize on the opportunities presented by the marketplace with our unique and innovative platform of software solutions.”

“As a leading software solution provider within the life sciences industry we want and need to be close to our customer base. This relocation will enable us to interact with our client base to build best in class solutions to cover the entire drug development life cycle – whether you are a small start-up operation or a global player” says Veluchamy.

About ArisGlobal:

ArisGlobal (www.arisglobal.com) specializes in the delivery of innovative, cloud compliant software solutions that facilitate global drug development and regulatory compliance within the Life Sciences and Healthcare industries. Its comprehensive portfolio supports the entire product life cycle including Clinical Development, Regulatory Affairs, Pharmacovigilance and Medical Communications.

ArisGlobal’s advanced technology solutions currently empower over 200 drug and device manufacturers, CROs and regulatory agencies to make better and more informed decisions, facilitate compliance, reduce risk and improve operational efficiency. Headquartered in the United States, ArisGlobal has regional offices in Europe, India and Japan.

LATEST NEWS

About ArisGlobal

ArisGlobal is transforming the way today’s most successful Life Sciences companies develop breakthroughs and bring new products to market. Our end-to-end drug development technology platform, LifeSphere®, integrates our proprietary Nava® cognitive computing engine to automate all core functions of the drug development lifecycle. Designed with deep expertise and a long-term perspective that spans more than 30 years, LifeSphere® is a unified platform that boosts efficiency, ensures compliance, delivers actionable insights, and lowers total cost of ownership through multi-tenant SaaS architecture.

Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan and China. For more updates, follow ArisGlobal on LinkedIn and Twitter.

Additional Information

Connect with ArisGlobal on LinkedIn: linkedin.com/company/aris-global
Follow @Aris_Global on Twitter: twitter.com/aris_global

Contact

Erika Thomas
ArisGlobal
+305-726-6601 | ethomas@arisglobal.com